Statistics for A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Total visits
| views | |
|---|---|
| A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782) | 3 |
Total visits per month
| views | |
|---|---|
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:c32d15c9-38e8-49f3-b48c-92803e8f904d | 33 |
| java.util.UUID:6e8e2447-e2e7-4d13-bbf1-32dee0a1d094 | 17 |
| java.util.UUID:ad000d98-7fe7-4618-b709-d87420d4d622 | 11 |
| Leal2022Phase1-CCBY.pdf | 8 |
Top country views
| views | |
|---|---|
| United States | 3 |
Top city views
| views | |
|---|---|
| Greenwood | 3 |